Daniel Kloster, MD
Interventional Pain Medicine · Overland Park, KSNPI 1346237088
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Spinal Simplicity, LLC at 34.3% of the total. Reporting peaked in 2020 at $195,932 and has fallen 64.3% since, to $70,037 in 2025.
Across 916 payments — averaging $956.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$300K
- Flowonix Medical Incorporated$156K
- Boston Scientific$94K
- Omnia Medical, LLC$82K
- Vertiflex, Inc.$73K
- Neuroone Medical Technologies Corporation$65K
- plus $105K from 24 others
Across 177 payments — averaging $3230.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$343K
- Flowonix Medical Incorporated$115K
- Nevro Corp.$61K
- Vertos Medical, Inc.$25K
- Si-bone, Inc.$22K
- Spinal Simplicity, LLC$6K
- plus $500 from 1 others
Across 6 payments — averaging $11,749 each. An ownership or investment interest held by the physician or an immediate family member.
- Spinal Simplicity, LLC$70K
What the payments were for
- Consulting fees$501,63257%
- Speaking & faculty fees$159,88618%
- Travel & lodging$90,75110%
- Food & beverage$41,5265%
- Education$82,5279%
- Entertainment$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 412 | $300,417 |
| Flowonix Medical Incorporated | 4 | $156,488 |
| Boston Scientific | 94 | $94,005 |
| Omnia Medical, LLC | 4 | $82,355 |
| Vertiflex, Inc. | 60 | $72,938 |
| Neuroone Medical Technologies Corporation | 16 | $64,853 |
| Abbott | 188 | $32,907 |
| Southern Spine, LLC | 4 | $19,125 |
| Zavation Medical Products, LLC | 11 | $17,437 |
| Genesys Orthopedics Systems, L.L.C. | 19 | $10,249 |
| Nevro Corp. | 49 | $10,039 |
| Vertos Medical, Inc. | 8 | $7,657 |
| Interventional Pain Technologies Inc. | 5 | $3,445 |
| Surgentec | 3 | $1,244 |
| Si-bone, Inc. | 4 | $548 |
| Relievant Medsystems, Inc. | 8 | $542 |
| Camber Spine Technologies LLC | 1 | $500 |
| Saluda Medical Americas, Inc. | 6 | $478 |
| Nalu Medical, Inc. | 5 | $395 |
| MML US, Inc. | 1 | $134 |
| Stimwave Technologies Incorporated | 1 | $130 |
| Curonix LLC | 1 | $98 |
| Tersera Therapeutics LLC | 1 | $92 |
| Globus Medical | 2 | $76 |
| Titan Surgical Group, LLC | 1 | $49 |
| SPR Therapeutics, Inc | 2 | $45 |
| AbbVie | 1 | $28 |
| Medtronic | 2 | $28 |
| Averitas Pharma Inc. | 1 | $25 |
| GRT US Holding, Inc. | 2 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$287,866
- Prometra II$156,488
- Superion ISS$71,925
- VERIFLEX$42,554
- SUPERION$31,784
- ZAVATION$27,292
- PROCLAIM$24,293
- SACROILIAC JOINT FUSION SYSTEM$17,811
- Zavation Medical Products, LLC$13,646
- WAVEWRITER ALPHA$11,638
- Vyrsa V1$7,735
- mild Device Kit$7,500
- Proclaim IPG$4,145
- LIBERTY SI$3,010
- Watchman$2,698
- GENERAL PAIN MANAGEMENT$2,076
- 3D GraftRasp System$1,187
- GENERAL - THERAPIES$1,130
- ETERNA$921
- Senza$675
How this compares
Too few interventional pain medicine providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 109 | $2,460 |
| Morphine Sulfate ErMorphine Sulfate | 52 | $1,727 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $1,673 |
| Methadone Hcl | 59 | $1,255 |
| Gabapentin | 60 | $879 |
| Cyclobenzaprine Hcl | 51 | $840 |
| Nortriptyline Hcl | 33 | $629 |
| Oxycodone Hcl | 56 | $620 |
| Tramadol Hcl | 66 | $478 |
| Tizanidine Hcl | 16 | $282 |
| Methylprednisolone | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Overland Park
- Mauricio GarciaOverland Park$8K
- Matthew NadlerOverland Park$5K
- Mark PinkertonOverland Park$177
- Manoj JagtianiHays$7K
- Mackenzie AndersonKansas City$4K
- Eugerie HanleyGalena$2K
- Roger MisasiPittsburg$2K
- Michael HearndonGalena$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.